Lloyd Fonds — Focus on building scale

Lloyd Fonds (DB: L1OA)

Last close As at 23/11/2024

10.30

−0.05 (−0.48%)

Market capitalisation

144m

More on this equity

Research: Financials

Lloyd Fonds — Focus on building scale

Lloyd Fonds (LF) continues its operational realignment process with Strategy 2023/2025 initiated in FY20. The new business model has been implemented under the Lloyd Liquid Assets segment, with €1.1bn of AUM gathered so far, and management reiterated its target to reach €7bn by 2024. The AI-based portfolio management (LAIC) has been successfully launched, with €15m in AUM raised so far. While the company reported a net loss in H120 results due to continued transformation costs and the COVID-19 crisis, management expects H220 to break even.

Milosz Papst

Written by

Milosz Papst

Head of Content, Investment Trusts

Financials

Lloyd Fonds

Focus on building scale

Fund management

Scale research report - Update

9 September 2020

Price

€4.56

Market cap

€61m

Share price graph

Share details

Code

L10A

Listing

Deutsche Börse Scale

Shares in issue

13.3m

Last reported net debt at 30 June 2020

€9.8m

Business description

Lloyd Fonds positions itself as an integrated asset manager and partner for private customers and institutional capital. It aims to provide added value through transparent, active asset management, forward-looking digital solutions with the secondary brand LAIC, as well as individual and institutional asset management. It has over 20 years’ experience as an investor in a range of alternative real assets.

Bull

Transformation to an active asset manager.

Ambitious targeted AUM growth.

Onboarding of new experienced management and sound balance sheet.

Bear

Execution risk in business repositioning.

Markets for legacy activities remain volatile.

Regulatory risks of inorganic growth.

Analyst

Milosz Papst

+44 (0)20 3077 5700

Lloyd Fonds (LF) continues its operational realignment process with Strategy 2023/2025 initiated in FY20. The new business model has been implemented under the Lloyd Liquid Assets segment, with €1.1bn of AUM gathered so far, and management reiterated its target to reach €7bn by 2024. The AI-based portfolio management (LAIC) has been successfully launched, with €15m in AUM raised so far. While the company reported a net loss in H120 results due to continued transformation costs and the COVID-19 crisis, management expects H220 to break even.

H120 financials: Higher share of new business

In H120, LF reported a 64% y-o-y growth in revenues, stemming primarily from the consolidation of SPSW Capital and Lange Assets & Consulting, both acquired in Q419. LF introduced new segment reporting, with its new asset management business delivering revenues of €3.6m (58% of group) and real assets generating €2.6m (down 31% y-o-y). As the business is still in realignment phase, it is bearing the increased costs of integration and is still loss-making at EBIT level; however, the loss was slightly lower year-on-year (€4.3m vs €4.6m in H119). LF’s net loss amounted to only €3.7m in H120, supported by €2.4m of tax loss carried forward.

New strategy on track

LF intends to continue its operations as an active investment manager and gather momentum by increasing its AUM. During H120, AUM increased by 5% to €1.1bn despite COVID-19-related difficulties in new client acquisition, and the FY20 AUM guidance stands at €1.4bn. The acquisition of the two entities in Q419 was a transformation milestone. Going forward, scale will be increased mostly organically and supported by further M&A. Meanwhile, we note that real assets include areas affected by global slowdown, including in particular container shipping and aviation.

Valuation: Discounting the future

LF shares trade at an FY21e EV/EBITDA multiple of 15.5x. As LF is still in transition, we compare its valuation to both real assets investing companies (LF trades at 6% premium) and asset management companies (35% premium). On FY22e estimates the premiums change respectively to 27% and an 8% discount, which we believe indicates a market expectation of successful implementation of the new strategy. In terms of P/E ratios on the other hand, LF trades at a sizeable premium to both subgroups, with an FY22e multiple of 24.6x.

Consensus estimates

Year
end

Revenue
(€m)

PBT
(€m)

EPS
(€)

DPS
(€)

P/E
(x)

Yield
(%)

12/18

7.9

(1.0)

(0.16)

0.0

N/A

N/A

12/19

8.2

(5.1)

(0.01)

0.0

N/A

N/A

12/20e

15.8

(5.1)

(0.16)

0.0

N/A

N/A

12/21e

22.6

0.2

0.01

0.0

608.0

N/A

Source: Refinitiv. Note: Consensus is based on the estimates of four analysts.

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

H120 financials: The cost of transformation

H120 was the first fiscal period when the majority (58%) of LF’s revenues came from its repositioned business model. Its top line grew by 64% y-o-y to €6.2m, mostly on the back of first-time consolidation of SPSW, while its legacy portfolio delivered €2.5m in sales (31% less year-on-year). Management highlighted that despite COVID-19-induced hurdles to client acquisition it managed to grow its assets under management (AUM) in the ‘liquid assets’ segment by 5% to €1.1bn vs end-FY19, which should translate into higher management fees in the forthcoming financial periods. Management confirmed its plan to reach €7bn AUM by 2024 (extended from 2023 earlier amid the COVID-19-outbreak). The real assets portfolio is in its realisation phase and management fees are diminishing. In H120 they amounted to €2.2m (15% lower year-on-year), and transaction fees related to disposals from the portfolio were at €0.4m – stemming from the sale of an office building in Utrecht (Fonds Holland V) – compared to €1.2m in H119 when LF sold three assets.

As the repositioning is still in progress, LF continues to bear the costs of the process. The headcount increased significantly due to acquisitions and resulted in 45% y-o-y higher personnel costs of €5.1m. The increase was followed by operating costs such as IT, supplies and support growing by low double-digit year-on-year percentages. This was partially offset by lower legal and advisory costs (-52% y-o-y) due to a high base effect in H119 related to implementation of the new strategy and reorganisation of the group. In consequence the EBIT loss of €4.3m was lower than in H119 (€4.6m).

On top of transaction fees, LF also generates gains and losses on the sale of assets in the legacy portfolio due to profit-sharing agreements. In H120 assets were sold at a €1.0m loss, which drove the net financial result to a €1.9m loss, compared to €5.3m income in H119 (as disposals in the period generated €5.0m profit). The remaining interest burden increased significantly (to €0.8m from €0.2m), due to consolidation of debt of acquired businesses, issuance of a convertible bond and IFRS 16 implementation and resulting leasing fees. Despite recognising €2.4m in tax loss carried forward, the net loss amounted to €3.9m, while in H119 net income amounted to €0.9m.

For FY20 management expects a net loss at a similar level to that reported in H120, indicating a break-even result in H220. This includes expected further gains from tax losses carried forward.

Exhibit 1: Financial highlights

€000s

H120

H119

y-o-y

Revenues

6,150

3,748

64.1%

Lloyd Fonds Liquid Assets

3,562

0

N/M

Lloyd Fonds Real Assets

2,578

3,748

(31.2%)

Lloyd Fonds Group

10

0

N/M

Cost of materials

(254)

(201)

26.4%

Personnel costs

(5,068)

(3,488)

45.3%

D&A

(1,794)

(344)

N/M

Other operating result

(3,535)

(4,548)

(22.3%)

Result from associates

209

264

(20.8%)

Operating earnings (EBIT)

(4,292)

(4,569)

(6.1%)

Financial income

134

5,451

-97.5%

Financial costs

(2,049)

(167)

N/M

Pre-tax profit

(6,207)

715

N/M

Income tax

2,437

209

N/M

Minorities

(154)

-

N/M

Net profit attributable to majority shareholders

(3,924)

924

N/M

Source: Lloyd Fonds

Strategy 2023/2025: Integrating new business lines

While the coronavirus outbreak caused significant disruption in financial markets and affected LF’s new business strategy from the demand side, the implementation of new business lines and integration of newly acquired businesses is on track. The three new distinct business lines form the segment ‘Lloyd Fonds Liquid Assets’ with total AUM of €1.1bn.

The Lloyd Fonds product line (formerly LF-Linie) currently comprises seven open-ended funds with total AUM of €800m (end-FY19: €785m). The funds have various risk profiles, from money market to equity funds. Lloyd Vermögen (former LF-Vermögen) is the asset management area of LF’s business. The company offers bespoke wealth management for individual and institutional investors, as well as family offices, and manages AUM of €300m. In Q419 LF acquired Lange Assets & Consulting which had AUM of €186m in this area.

The third area is LAIC, where LF raised €15m AUM in individual portfolio management so far. The portfolios are managed by a fully digitalised, AI-based management system, LAIC Advisor. The algorithm selects a unique mix of instruments from c 10k actively managed, open-ended investment funds and c 400 ETFs to maximise profits, as described in detail in our previous note. LAIC Advisor is also developed to support other business areas of LF, as well as new product development. In May 2020, LF launched five mixed funds and since August 2020 offers unit-linked pension insurance in partnership with Helvetia Versicherung and Condor Versicherung. In October it plans to launch portfolio solutions for institutional investors – all based on LAIC Advisor technology.

The targeted growth in AUM from €1bn to €7bn should see contributions from all areas, both organically and through acquisitions. Possible acquisition targets could be found in the wealth management area, given the fragmented German market. Acquisitions are more likely to be completed in 2021–22 and could be fuelled by further equity issues.

Alongside the implementation of a new strategy and integration of acquired companies, LF also changed its management board composition, which has been narrowed to two members, with Klaus Pinter leaving the board. He was acting as CFO before 15 April 2020, and his responsibilities have been taken over by recently appointed CEO Achim Plate. The second board member is Michael Schmidt (appointed in April 2019), who acts as CIO and is responsible for the legal department and the product lines of Lloyd Fonds and Lloyd Vermögen.

Two out of five members of the supervisory board have been substituted due to conflicts of interest arising from the integration of acquired entities. Achim Plate and Henning Soltau are co-founders of SPSW and had been members of LF’s supervisory board since April 2018. Following the acquisition of SPSW, Plate was appointed LF’s CEO, and Soltau is managing director and minority shareholder of SPSW Capital. They have been replaced on the supervisory board by Jörg Ohlsen (former partner at Deloitte and KPMG) and Peter Zahn (former executive director at Lang & Schwarz Broker and an independent management consultant since June 2020).

New businesses become dominant in LF’s results

With the successful integration of SPSW Capital and Lange Assets & Consulting, the new business lines became the main drivers of LF’s consolidated results and encouraged management to update its reporting segments. The segments of Real Estate, Shipping and Other Assets (mostly air transport) were amalgamated into Lloyd Fonds Real Assets, which combines LF’s legacy business. In H120, LF Real Assets generated 42% of group revenues. It continues to generate predictable (albeit declining) revenues and may still contribute meaningfully to LF’s top line in FY20–22.

Exhibit 2: Lloyd Fonds’s change in reporting segments

NEW

Lloyd Fonds Real Assets

Lloyd Fonds Liquid Assets

Lloyd Fonds

Lloyd Vermögen

LAIC

OLD

Real estate

Shipping

Other assets

N/A

Source: Lloyd Fonds

The real estate operations consist of three funds that lease a total of 28.5k sqm of office (60%) and hotel (40%) space. As at end-H120 the buildings are fully let. During H120 LF sold another building (on top of four disposed of in FY19 as described in our earlier note), which yielded a 127% return to the fund investors. The return includes cash flows received over the course of the fund’s life as the final settlement was below the book value of the asset. The office building is fully let to Deloitte in Utrecht, the Netherlands, and was sold in March 2020 to a French institutional investor

As at end-H120 LF’s shipping business consists of 15 ships and two secondary market funds. The former includes nine container ships with a total capacity of 8,500 TEU and six tankers. Management highlights that tankers performed well during H120, with two vessels delivering 15% and 16% distributions to investors. LF also has indirect exposure, through the secondary funds, to 56 vessels. The third fund is under a liquidation process. The broader shipping industry has been affected by the COVID-19 crisis, especially in the container shipping segment. We note that there has been a significant fall in charter rates and an increase in the number of unused ships. The market is slowly recovering and market participants are cautiously optimistic according to LF.

Within the other assets segment, at end-June 2020 LF managed three airplane funds, one private equity fund and eight British life insurance funds. The airplane funds manage three planes, leased to Singapore Airlines and Chair Airlines. The aviation industry has been strongly hit by the slowdown in global trade and travel restrictions. Management highlights that it cannot rule out that airlines will not extend their leasing contracts or that extension options will not be exercised.

Valuation

As Lloyd Fonds’ transformation progresses, we have decided to expand the peer group. On FY21e EV/EBITDA, LF trades at a significant premium to both real asset investment and asset management groups (with an expected loss in FY20), and at a discount on FY22, which may reflect market expectations of the successful implementation of the new strategy. As a point of reference Scalable Capital, which is a privately owned asset manager developing a robo-investment platform with AUM of €2bn, recently closed a US$58m funding round. The capital raise implied a post-money valuation of the company of €400m according to TechCrunch.

Exhibit 3: Peer group comparison

Market cap

P/E (x)

EV/EBITDA (x)

(€m)

2020e

2021e

2022e

2020e

2021e

2022e

Lloyd Fonds

60

N/A

608.0

24.6

N/A

15.5

9.1

MPC Capital

50

N/A

19.7

12.9

N/A

12.9

5.3

Corestate Capital

366

5.2

3.6

3.1

7.9

6.2

5.8

VIB Vermogen

757

11.7

10.3

10.4

19.0

17.7

16.5

TLG Immobilien

1,890

40.1

10.1

11.6

23.9

21.9

21.8

Patrizia

2,244

33.6

27.6

24.8

16.7

14.6

13.5

Real asset investment average

1,061

22.7

14.3

12.5

16.9

14.7

12.6

Premium/(discount) to peers

-94%

N/M

N/M

96%

N/M

6%

-27%

Frenkel Topping

50

23.5

18.4

15.7

17.0

13.2

11.5

Impax Asset Management

746

42.9

33.3

26.8

31.0

24.5

19.9

Flatex

1,098

22.1

16.3

13.4

16.4

11.7

10.0

Jupiter Fund Management

1,283

10.0

9.1

8.6

6.0

5.0

4.8

Man Group

1,962

13.0

9.7

8.1

8.8

7.2

6.4

Azimut Holding

2,286

10.0

9.9

9.4

8.9

9.0

8.5

Ashmore Group

3,040

14.7

15.2

14.3

8.7

9.5

8.8

Asset management average

1,495

19.5

16.0

13.8

13.8

11.5

10.0

Premium/(discount) to peers

-96%

N/M

391%

79%

N/M

35%

-8%

Source: Refinitiv. Note: Consensus is based on the estimates of four analysts. Priced at 7 September 2020.

General disclaimer and copyright

Any Information, data, analysis and opinions contained in this report do not constitute investment advice by Deutsche Börse AG or the Frankfurter Wertpapierbörse. Any investment decision should be solely based on a securities offering document or another document containing all information required to make such an investment decision, including risk factors. This report has been commissioned by Deutsche Börse AG and prepared and issued by Edison for publication globally.

Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2020 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Lloyd Fonds

View All

Latest from the Financials sector

View All Financials content

Research: Healthcare

Oasmia Pharmaceutical — An appealing metamorphosis

Oasmia is a specialty pharma company focused on developing improved formulations of well-established cancer drugs through its proprietary XR-17 platform technology. Its technology has received validation though a global partnership deal for lead asset Apealea (Cremophor-free paclitaxel) with Elevar Therapeutics across a variety of cancer indications. Apealea’s initial indication is ovarian cancer (approved in Europe), and Elevar is in discussions with the FDA for the pathway to US approval (we forecast launch in FY23). Oasmia’s newly appointed management has defined a strategy to realign the business, further leverage on its platform competencies and expand its pipeline through acquisitions as it moves to the ultimate goal of sustainable profitability. We value Oasmia at SEK2.82bn or SEK6.29/share.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free